We are live on ! Find out more
FC

Fairscale Capital Portfolio holdings

AUM $167M Turnover 2.25%
1-Year Est. Return 28.67%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+28.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$22.8M
Cap. Flow
+$1.04M
Cap. Flow %
0.62%
Top 10 Hldgs %
52.44%
Holding
444
New
7
Increased
24
Reduced
43
Closed
3
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$222K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$126K
3
NVDA icon
NVIDIA
NVDA
+$118K
4
FCX icon
Freeport-McMoran
FCX
+$107K
5
SNPS icon
Synopsys
SNPS
+$101K

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.24%
2 Technology 20.89%
3 Financials 6.18%
4 Communication Services 6%
5 Consumer Discretionary 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TMO icon
26
Thermo Fisher Scientific
TMO
$255B
$1.17M 0.7%
2,327
-59
-2% -$28.3K
2024 Q2
8 quarters
MDYG icon
27
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.8B
$1.04M 0.62%
9,255
-278
-3% -$29.5K
2024 Q2
8 quarters
CRWD icon
28
CrowdStrike
CRWD
$233B
$1M 0.6%
5,244
– –
2024 Q2
8 quarters
PANW icon
29
Palo Alto Networks
PANW
$278B
$986K 0.59%
2,891
+127
+5% +$29.1K
2024 Q2
8 quarters
JNJ icon
30
Johnson & Johnson
JNJ
$625B
$960K 0.57%
3,779
-22
-0.6% -$5.13K
2024 Q2
8 quarters
VTHR icon
31
Vanguard Russell 3000 ETF
VTHR
$4.91B
$887K 0.53%
2,676
– –
2024 Q2
8 quarters
VB icon
32
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
$886K 0.53%
2,923
– –
2024 Q2
8 quarters
RTX icon
33
RTX Corp
RTX
$260B
$857K 0.51%
4,519
-27
-0.6% -$4.95K
2024 Q2
8 quarters
VOE icon
34
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.1B
$835K 0.5%
4,224
+994
+31% +$192K
2024 Q2
8 quarters
GLW icon
35
Corning
GLW
$114B
$827K 0.49%
3,237
– –
2024 Q2
8 quarters
VOOG icon
36
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
$799K 0.48%
9,671
+239
+3% +$19K
2024 Q2
8 quarters
VUG icon
37
Vanguard Morningstar Growth ETF
VUG
$229B
$770K 0.46%
8,940
– –
2024 Q2
8 quarters
IJJ icon
38
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.59B
$765K 0.46%
5,181
+204
+4% +$28.9K
2024 Q2
8 quarters
HACK icon
39
Amplify Cybersecurity ETF
HACK
$3.31B
$738K 0.44%
7,030
-80
-1% -$7.06K
2024 Q3
7 quarters
LLY icon
40
Eli Lilly
LLY
$1.15T
$715K 0.43%
596
– –
2024 Q2
8 quarters
CRM icon
41
Salesforce
CRM
$199B
$688K 0.41%
4,378
-253
-5% -$44.5K
2024 Q2
8 quarters
AMAT icon
42
Applied Materials
AMAT
$321B
$687K 0.41%
950
+113
+14% +$52.1K
2024 Q2
8 quarters
CMI icon
43
Cummins
CMI
$73.9B
$683K 0.41%
958
– –
2024 Q2
8 quarters
UNH icon
44
UnitedHealth
UNH
$377B
$658K 0.39%
1,584
-65
-4% -$24.1K
2024 Q2
8 quarters
SLYG icon
45
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.77B
$637K 0.38%
5,349
+293
+6% +$31.7K
2024 Q2
8 quarters
MRK icon
46
Merck
MRK
$365B
$629K 0.38%
4,863
– –
2024 Q2
8 quarters
PLTR icon
47
Palantir
PLTR
$465B
$609K 0.36%
5,221
+146
+3% +$19.9K
2024 Q2
8 quarters
SLYV icon
48
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.75B
$609K 0.36%
5,579
+802
+17% +$82.6K
2024 Q2
8 quarters
NEE icon
49
NextEra Energy
NEE
$164B
$606K 0.36%
6,909
– –
2024 Q2
8 quarters
BX icon
50
Blackstone
BX
$87.8B
$603K 0.36%
5,121
-1
-0% -$120
2024 Q2
8 quarters

Similar funds

Fairscale Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Fairscale Capital held 444 positions worth $167M, up 16% from $145M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 2.3%. Fairscale Capital opened 7 new positions and exited 3, leaving the 444-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

  • Fairscale Capital's largest Q2 2026 buy was Calamos S&P 500 Structured Alt Protection ETF - June: 7,230 shares worth $200K.
  • Fairscale Capital added most to Invesco QQQ Trust in Q2 2026, an estimated $566K increase.
  • Fairscale Capital's biggest Q2 2026 reduction was Amgen, cutting an estimated $222K.
  • Fairscale Capital fully exited Hologic in Q2 2026, selling an estimated $34.2K.
  • Fairscale Capital's ten largest holdings make up 52% of its $167M portfolio in Q2 2026.
  • Fairscale Capital opened 7 new positions and closed 3 in Q2 2026.
  • Fairscale Capital's portfolio value rose 16% quarter-over-quarter to $167M.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.